Levinstein Marjorie相关文献与解析，生知库

Gomez Juan L, Magnus Christopher J, Bonaventura Jordi, Solis Oscar, Curry Fallon P, Levinstein Marjorie R, Budinich Reece C, Carlton Meghan L, Ventriglia Emilya N, Lam Sherry, Wang Le, Schoenborn Ingrid, Dunne William, Michaelides Michael, Sternson Scott M

发表日期：2025

文献求助收藏

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

重新定义氯胺酮的抗抑郁药理学：NMDA受体和阿片受体的协同作用？

期刊:American Journal of Psychiatry

影响因子:14.7

doi:10.1176/appi.ajp.20240378

Levinstein, Marjorie R; Budinich, Reece C; Bonaventura, Jordi; Schatzberg, Alan F; Zarate, Carlos A Jr; Michaelides, Michael

Locomotor activity depends on β-arrestin recruitment by the dopamine D(1) receptor in the striatal D(1)-D(3) receptor heteromer

运动活性依赖于纹状体D(1)-D(3)受体异聚体中多巴胺D(1)受体募集β-arrestin。

期刊:Pharmacological Research

影响因子:10.5

doi:10.1016/j.phrs.2025.107826

Evans, Alexandra H; Ciruela-Jardí, Marc; Rea, William; Keegan, Bradley M; Levinstein, Marjorie R; Bonifazi, Alessandro; Cao, Jianjing; Jackson, Shelley N; Shi, Lei; Casajuana-Martin, Nil; Cai, Ning-Sheng; Casadó, Vicent; Earley, Christopher J; Newman, Amy H; Michaelides, Michael; Pardo, Leonardo; Moreno, Estefanía; Ferré, Sergi

信号转导

发表日期：2025

文献求助收藏

Bifunctional Modulation of NMDA and Opioid Receptors in Ketamine Reinforcement and Misuse: Implications for Substance Use Disorder Treatment

氯胺酮强化和滥用中NMDA受体和阿片受体的双功能调节：对物质使用障碍治疗的启示

期刊:Biological Psychiatry

影响因子:9

doi:10.1016/j.biopsych.2025.11.021

Levinstein, Marjorie R; Schoenborn, Ingrid; Manza, Peter; Schatzberg, Alan F; Zarate, Carlos A Jr; Jordi Bonaventura; Michaelides, Michael

信号转导

发表日期：2025

文献求助收藏

Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

μ-阿片受体配体(S)-美沙酮具有独特的药效学特性和低滥用风险

期刊:Molecular Psychiatry

影响因子:10.1

doi:10.1038/s41380-023-02353-z

Levinstein, Marjorie R; De Oliveira, Paulo A; Casajuana-Martin, Nil; Quiroz, Cesar; Budinich, Reece C; Rais, Rana; Rea, William; Ventriglia, Emilya N; Llopart, Natàlia; Casadó-Anguera, Verònica; Moreno, Estefanía; Walther, Donna; Glatfelter, Grant C; Weinshenker, David; Zarate, Carlos A Jr; Casadó, Vicent; Baumann, Michael H; Pardo, Leonardo; Ferré, Sergi; Michaelides, Michael

信号转导

发表日期：2024

文献求助收藏

InÂ vivo photopharmacology with light-activated opioid drugs.

利用光激活阿片类药物进行体内光药理学研究

期刊:Neuron

影响因子:15

doi:10.1016/j.neuron.2023.09.017

McClain Shannan P, Ma Xiang, Johnson Desiree A, Johnson Caroline A, Layden Aryanna E, Yung Jean C, Lubejko Susan T, Livrizzi Giulia, He X Jenny, Zhou Jingjing, Chang-Weinberg Janie, Ventriglia Emilya, Rizzo Arianna, Levinstein Marjorie, Gomez Juan L, Bonaventura Jordi, Michaelides Michael, Banghart Matthew R

Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability

μ阿片受体激活介导(S)-氯胺酮在大鼠体内的强化作用：对滥用责任的启示

期刊:Biological Psychiatry

影响因子:9

doi:10.1016/j.biopsych.2022.12.019

Levinstein, Marjorie R; Carlton, Meghan L; Di Ianni, Tommaso; Ventriglia, Emilya N; Rizzo, Arianna; Gomez, Juan L; Budinich, Reece C; Shaham, Yavin; Airan, Raag D; Zarate, Carlos A Jr; Bonaventura, Jordi; Michaelides, Michael

6-O-(2-[(18)F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([(18)F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo

6-O-(2-[(18)F]氟乙基)-6-O-去甲基-二丙诺啡 ([(18)F]FE-DPN) 在体内优先与μ阿片受体结合

期刊:Molecular Imaging and Biology

影响因子:2.5

doi:10.1007/s11307-022-01767-5

Levinstein, Marjorie R; Ventriglia, Emilya N; Gomez, Juan L; Budinich, Reece C; Marton, János; Henriksen, Gjermund; Holt, Daniel P; Dannals, Robert F; Pomper, Martin G; Zarate, Carlos A Jr; Bonaventura, Jordi; Michaelides, Michael

信号转导

发表日期：2023

文献求助收藏

In vivo photopharmacology with light-activated opioid drugs

利用光激活阿片类药物进行体内光药理学研究

期刊:

影响因子:

doi:10.1101/2023.02.02.526901

McClain, Shannan P; Ma, Xiang; Johnson, Desiree A; Johnson, Caroline A; Layden, Aryanna E; Yung, Jean C; Lubejko, Susan T; Livrizzi, Giulia; Jenny He, X; Zhou, Jingjing; Ventriglia, Emilya; Rizzo, Arianna; Levinstein, Marjorie; Gomez, Juan L; Bonaventura, Jordi; Michaelides, Michael; Banghart, Matthew R

发表日期：2023

文献求助收藏

Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone

μ-阿片受体配体(S)-美沙酮具有独特的药效学特性和低滥用风险

期刊:

影响因子:

doi:10.21203/rs.3.rs-2644719/v1

Michaelides, Michael; Levinstein, Marjorie; De Oliveira, Paulo; Casajuana-Martin, Nil; Quiroz, Cesar; Budinich, Reece; Rais, Rana; Rea, William; Ventriglia, Emilya; Llopart, Natàlia; Casadó-Anguera, Verònica; Moreno, Estefanía; Walther, Donna; Glatfelter, Grant; Weinshenker, David; Zarate, Carlos; Casado, Vicent; Baumann, Michael; Pardo, Leonardo; Ferre, Sergi

信号转导

发表日期：2023

文献求助收藏

Cocaine chemogenetics blunts drug-seeking by synthetic physiology.

可卡因化学遗传学通过合成生理学抑制药物渴求。

Redefining Ketamine Pharmacology for Antidepressant Action: Synergistic NMDA and Opioid Receptor Interactions?

重新定义氯胺酮的抗抑郁药理学：NMDA受体和阿片受体的协同作用？

Locomotor activity depends on β-arrestin recruitment by the dopamine D(1) receptor in the striatal D(1)-D(3) receptor heteromer

运动活性依赖于纹状体D(1)-D(3)受体异聚体中多巴胺D(1)受体募集β-arrestin。

Bifunctional Modulation of NMDA and Opioid Receptors in Ketamine Reinforcement and Misuse: Implications for Substance Use Disorder Treatment

氯胺酮强化和滥用中NMDA受体和阿片受体的双功能调节：对物质使用障碍治疗的启示

Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

μ-阿片受体配体(S)-美沙酮具有独特的药效学特性和低滥用风险

InÂ vivo photopharmacology with light-activated opioid drugs.

利用光激活阿片类药物进行体内光药理学研究

Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability

μ阿片受体激活介导(S)-氯胺酮在大鼠体内的强化作用：对滥用责任的启示

6-O-(2-[(18)F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([(18)F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo

6-O-(2-[(18)F]氟乙基)-6-O-去甲基-二丙诺啡 ([(18)F]FE-DPN) 在体内优先与μ阿片受体结合

In vivo photopharmacology with light-activated opioid drugs

利用光激活阿片类药物进行体内光药理学研究

Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone

μ-阿片受体配体(S)-美沙酮具有独特的药效学特性和低滥用风险